Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This research addresses a persistent threat to individuals with cystic fibrosis—Pseudomonas aeruginosa bacteria, known for biofilm formation and antibiotic resistance. Unlike prior studies on natural products, this initiative explores the combined impact of conventional antibiotics and MHCombiotics Inc.’s unique blend of metalloid and plant-based compounds. Demonstrated effective against P. aeruginosa, this study compares their efficacy to traditional antibiotics, seeking optimal combinations. Using experiments and a P. aeruginosa pneumonia mouse model, the research aims to unveil the anti-inflammatory, antioxidant, and antimicrobial properties of combiotics also presents a promising solution to combat respiratory infections and address antibiotic resistance, potentially enhancing P. aeruginosa infection treatment and offering crucial insights for improved respiratory care.
Raymond Turner
MHCombiotic Inc.
Life Sciences
Health and Related Sciences & Technology; Professional, scientific and technical services
University of Calgary
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.